» Articles » PMID: 36546452

Patient-reported Fatigue and Pain in Erdheim-Chester Disease: a Registry-based, Mixed Methods Study

Citing Articles

Langerhans cell histiocytosis: NACHO update on progress, chaos, and opportunity on the path to rational cures.

Bielamowicz K, Dimitrion P, Abla O, Bomken S, Campbell P, Collin M Cancer. 2024; 130(14):2416-2439.

PMID: 38687639 PMC: 11214602. DOI: 10.1002/cncr.35301.


Dyadic communication in rare cancer: a registry-based study of patients with Erdheim-Chester disease and their caregivers.

Reiner A, Applebaum A, Bossert D, Buthorn J, Sigler A, Fournier D Blood Adv. 2023; 7(19):5904-5910.

PMID: 37540824 PMC: 10558707. DOI: 10.1182/bloodadvances.2023010827.

References
1.
Mendoza T, Wang X, Cleeland C, Morrissey M, Johnson B, Wendt J . The rapid assessment of fatigue severity in cancer patients: use of the Brief Fatigue Inventory. Cancer. 1999; 85(5):1186-96. DOI: 10.1002/(sici)1097-0142(19990301)85:5<1186::aid-cncr24>3.0.co;2-n. View

2.
Estrada-Veras J, OBrien K, Boyd L, Dave R, Durham B, Xi L . The clinical spectrum of Erdheim-Chester disease: an observational cohort study. Blood Adv. 2017; 1(6):357-366. PMC: 5446206. DOI: 10.1182/bloodadvances.2016001784. View

3.
Neufeld N, Elnahal S, Alvarez R . Cancer pain: a review of epidemiology, clinical quality and value impact. Future Oncol. 2016; 13(9):833-841. DOI: 10.2217/fon-2016-0423. View

4.
Cavalli G, Guglielmi B, Berti A, Campochiaro C, Sabbadini M, Dagna L . The multifaceted clinical presentations and manifestations of Erdheim-Chester disease: comprehensive review of the literature and of 10 new cases. Ann Rheum Dis. 2013; 72(10):1691-5. DOI: 10.1136/annrheumdis-2012-202542. View

5.
Mao H, Bao T, Shen X, Li Q, Seluzicki C, Im E . Prevalence and risk factors for fatigue among breast cancer survivors on aromatase inhibitors. Eur J Cancer. 2018; 101:47-54. PMC: 6148367. DOI: 10.1016/j.ejca.2018.06.009. View